N/A
N=48
Standardized Versus Tailored Implementation of Measurement Based Care for Depression
Depression
Bottom Line
View on ClinicalTrials.gov: NCT02266134 ↗Enrolled (actual)
48
Serious AEs
5.7%
Results posted
Jun 2023
Primary outcome: Primary: Patient Health Questionnaire — 18.04; 16.77; 12.15; 13.09 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Tailored Implementation of Measurement Based Care (Behavioral); Standard Implementation of Measurement Based Care (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Health Questionnaire |
18.04; 16.77; 12.15; 13.09 | — |
| PRIMARY PHQ-9 Completed Fidelity |
4894; 5270; 1564; 860; 1112; 1986 | — |
Summary
Depression remains among the nation's top 10 chronic illnesses, costing over $80 billion annually; however, Measurement Based Care (MBC) is a relatively simple evidence-based intervention framework that has been shown to improve outcomes for depressed clients by identifying those who are not making progress and reducing the likelihood that clients will deteriorate in treatment. Despite the demonstrated effectiveness of MBC, the majority of community mental health counselors do not regularly assess target problem symptoms to guide their work. This study will test a standardized versus a tailored approach to implementing MBC that will include the integration of symptom monitoring capacities into the electronic health record system of one of the nation's largest not-for-profit providers of behavioral health services.
Eligibility Criteria
To be included, Patients must:
- be age 18 or above at time of enrollment;
- have depression as one of their primary treatment foci based on diagnosis made by clinicians using usual care interview methods to reflect major depressive disorder, dysthymic disorder, depressive disorder NOS, adjustment disorder with depressed mood;
- have significant depressive symptom severity (PHQ-9 total score > 9);
- receive individual psychotherapy;
- be fluent in English; and
- receive therapy from an enrolled study clinician during the proposed funding period
Patients will be excluded if they have an inability to sign the consent form (due to lack of competence or inability to read).
Therapist Inclusion Criteria -- Therapists must:
- be a practicing clinician at Centerstone; and
- see at least one adult (18+) patient
Therapist Exclusion Criteria: N/A
Data sourced from ClinicalTrials.gov (NCT02266134). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.